AnPac Bio-Medical Science Co. Ltd. (ANPC) shares are trading at lower $6.20 and the avg recommendation for the stock is Moderate Buy.
To add more color to this target, the company’s high over the last year is $12.18 and the low is $3.15 while the S&P 500 is up 15.29%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
Find out when ANPC reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
FREE CONFIDENTIAL REPORT
3 Stocks Set To Soar By January 1st, 2021
You have Successfully Subscribed!
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. ANPC has a short ratio of 0.03 and outstanding shares of 12.90M.
ANPC has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 8.44 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.03. AnPac Bio-Medical Science Co. Ltd. ANPC also noted assets of $7.71 million at the end of the last quarter. Investors should also keep an eye on sector updates as ANPC has historically followed its peers on positive news.
All told, AnPac Bio-Medical Science Co. Ltd. ANPC has strung together solid data and demonstrated underlying fundamentals. At its current valuation, ANPC represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
AnPac Bio-Medical Science Co. Ltd. ANPC is now commanding a market cap of 79.98M and a float of 1.33M. ANPC is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of ANPC stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in ANPC, either long or short, and we have not been compensated for this article.